Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05128006 · ClinicalTrials.gov registry record
Direct-to-patient Teledermatology and Computer-assisted Diagnosis
A clinical trial of New Patient Use of Teledermatology Mobile App, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- 63,200
- Enrollment target
- 3
- Study locations
NCT05128006 is a study of New Patient Use of Teledermatology Mobile App that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 63,200 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT05128006, a study of New Patient Use of Teledermatology Mobile App, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- 63,200 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligence system, and understand key stakeholders' attitudes regarding and readiness for remote dermatology care.
Conditions Studied
Interventions
- OTHER New patient teledermatology visit
Study Locations (3)
California
- San Francisco VA Medical Center, San Francisco, CA - San Francisco
Colorado
- Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora
Georgia
- Atlanta VA Medical and Rehab Center, Decatur, GA - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63,200 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2026-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05128006
The ClinicalTrials.gov registry entry for NCT05128006 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 63,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with New Patient Use of Teledermatology Mobile App appearing as the primary indexed condition, and to 1 intervention - of which New patient teledermatology visit is the first listed.
NCT05128006 reports 3 study locations spanning 3 distinct geographic areas - top geographies include California, Colorado, Georgia.
Frequently Asked Questions
What is clinical trial NCT05128006 about?
NCT05128006 is a clinical study titled "Direct-to-patient Teledermatology and Computer-assisted Diagnosis". This study will examine access to dermatology care. The operational partner will implement a direct-to-new patient teledermatology clinical care pathway while the research will study the effects of that implementation, use data associated with deployment to develop and test an Artificial Intelligenc...
What is the current status of trial NCT05128006?
This trial is currently recruiting. The enrollment target is 63,200 participants. The study started on 2022-11-07. Estimated completion is 2026-09-30.
What conditions does trial NCT05128006 study?
This clinical trial studies the following conditions: New Patient Use of Teledermatology Mobile App.
What interventions are being tested in trial NCT05128006?
The interventions under investigation include: New patient teledermatology visit (OTHER).
Who is sponsoring clinical trial NCT05128006?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05128006 being conducted?
This trial has 3 study locations across California, Colorado, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.